IP Library Granted Patent US 10,912,862
Granted Patent B2
US 10,912,862 · App. 14/377,128 · Granted Feb 9, 2021

Multi-layer biomaterial for tissue regeneration and wound healing

Inventors: Joshua R. Mauney (Watertown, MA); Carlos R. Estrada (Brookline, MA); David L. Kaplan (Concord, MA); Eun Seok Gil (Lexington, MA)
Assignees: Children's Medical Center Corporation; Tufts University
A61L27/227A61L27/3604A61L27/3834A61L27/54A61L27/56A61L27/58B29C39/003A61L2300/22A61L2300/254A61L2300/256A61L2300/258A61L2300/406A61L2300/41A61L2300/412A61L2300/414A61L2300/43A61L2300/608A61L2430/22B29L2031/755B29L2031/7532
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,912,862
App. No.
14/377,128
Granted
Feb 9, 2021
Kind
B2
Abstract

The technology described herein is directed to compositions comprising at least a first porous biomaterial layer and a second impermeable biomaterial layer and methods relating thereto. In some embodiments, the compositions and methods described herein relate to wound healing, e.g. repair of wounds and/or tissue defects.

Claims (37)

1. A multilayer biomaterial composition, comprising:

a first and second layer;

the first layer comprising a porous biomaterial matrix, wherein the porous biomaterial matrix comprises silk fibroin, and

the second layer comprising an impermeable biomaterial layer, wherein the impermeable biomaterial layer is characterized in that it prevents passage of liquid water across it,

wherein a bottom surface of the second layer contacts and/or covers a top surface of the first layer,

wherein the multilayer biomaterial composition has a shape selected from the group consisting of approximately a contoured sheet, a plane, a cuboid a sheet, and a tube, so that the multilayer biomaterial composition, when positioned at a site of a wound or defect, a bottom surface of the first layer is oriented such that the porous biomaterial matrix of the first layer is in contact with the wound or defect and provides a scaffold for tissue regeneration and the impermeable biomaterial layer provides a seal that prevents passage of cellular material, fluids, hollow organ contents, and/or particles into the site.

2. The composition of claim 1 , wherein the matrix is a structure selected from the group consisting of: foams; hydrogels; electrospun fibers; gels; fiber mats; sponges; 3-dimensional scaffolds; non-woven mats; woven materials; knit materials; fiber bundles; and fibers.

3. The composition of claim 1 , wherein the biomaterial of the impermeable biomaterial layer is selected from the group consisting of: silk fibroin; PGA; collagen; polyethylene oxide, fibronectin, keratin, polyaspartic acid, polylysin, alginate, chitosan, chitin, and hyaluronic acid.

4. The composition of claim 1 , wherein the first and second layers comprise silk fibroin.

5. The composition of claim 1 , wherein the second layer comprises a biomaterial that is not silk fibroin.

6. The composition of claim 1 , further comprising an agent.

7. The composition of claim 1 , wherein the average pore size of the porous silk fibroin matrix is at least 200 μm.

8. The composition of claim 1 , wherein the average pore size of the porous silk fibroin matrix is from about 200 μm to about 600 μm.

9. The composition of claim 1 , wherein the impermeable biomaterial layer is from about 10 μm to about 600 μm thick.

10. The composition of claim 1 , wherein the composition is from about 0.01 cm to about 5 cm thick.

11. The multilayer biomaterial composition of claim 1 , wherein the wound or defect is a hollow organ wound or defect.

12. The multilayer biomaterial composition of claim 11 , wherein the hollow organs include a bladder; a portion of a gastrointestinal tract; a stomach; and/or intestines.

13. The multilayer biomaterial composition of claim 12 , wherein the portion of the gastrointestinal tract is an esophagus.

14. The multilayer biomaterial composition of claim 1 , when positioned at site of wound or defect, the composition is sutured.

15. The multilayer biomaterial composition of claim 1 , wherein the composition is characterized by an elastic modulus up to about 2.7 MPa.

16. The multilayer biomaterial composition of claim 1 , wherein the composition is characterized by an extensibility between about 25% and about 500%.

17. The multilayer biomaterial composition of claim 1 , wherein the shape is the contoured sheet is curved, arced, or angled such that it matches a contour of tissue to be regenerated.

18. The multilayer biomaterial composition of claim 1 , wherein an edge of the impermeable biomaterial layer extends beyond the porous biomaterial matrix.

19. The multilayer biomaterial composition of claim 1 , wherein the impermeable biomaterial layer is annealed.

20. The composition of claim 1 , wherein the second layer comprises an impermeable layer of silk fibroin.

21. A method of producing a composition of claim 1 , the method comprising;

contacting a porous biomaterial matrix with an impermeable biomaterial layer, wherein the porous biomaterial matrix comprises silk fibroin.

22. The method of claim 21 , wherein the method further comprises adding an agent to at least one layer.

23. The method of claim 22 , wherein the agent is a therapeutic agent.

24. A method of producing a composition of claim 1 , the method comprising;

(a) casting an admixture of aqueous biomaterial solution and NaCl, wherein the aqueous biomaterial solution comprises silk fibroin;

(b) contacting the composition resulting from step (a) with water.

25. The method of claim 24 , wherein step (a) is performed with the solution in contact with a pre-existing impermeable biomaterial layer.

26. The method of claim 24 , wherein the admixture is cast for from about 12 hours to about 96 hours.

27. The method of claim 24 , wherein step (b) proceeds for from about 12 hours to about 120 hours.

28. The method of claim 24 , wherein the water is removed and replaced with a fresh volume of water at least once during step (b).

29. The method of claim 24 , wherein, during the casting step, the admixture of biomaterial solution and NaCl is in contact with an impermeable biomaterial layer.

Assignments (4)
CONFIRMATORY LICENSE Recorded Apr 4, 2022
From: BOSTON CHILDREN'S HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 059580/0270 →
CONFIRMATORY LICENSE Recorded Apr 10, 2020
From: BOSTON CHILDREN'S HOSPITAL
To: NIH-DEITR
Reel/Frame 052368/0022 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2015
From: MAUNEY, JOSHUA R.; ESTRADA, CARLOS R.
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 035462/0967 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2015
From: KAPLAN, DAVID L.; GIL, EUN SEOK
To: TUFTS UNIVERSITY
Reel/Frame 034694/0562 →
Continuity (2)
Provisional Application 61595233 · Feb 6, 2012
Related Publication 20150086605A1 · Mar 26, 2015